The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Radioembolization for hepatocellular carcinoma
Open accessAbstract
Radioembolization is a form of brachytherapy in which intra-arterially injected (90)Y-loaded microspheres serve as sources for internal radiation purposes. It produces average disease control rates above 80% and is usually very well tolerated. Main complications do not result from the microembolic effect, even in patients with portal vein occlusion, but rather from an excessive irradiation of non-target tissues including the liver. All the evidence that support the use of radioembolization in HCC is based on retrospective series or non-controlled prospective studies. However, reliable data can be obtained from the literature, particularly since the recent publication of large series accounting for nearly 700 patients. When compared to the standard of care for the intermediate and advanced stages (transarterial embolization and sorafenib), radioembolization consistently provides similar survival rates. Two indications seem particularly appealing in the boundaries of these stages for first-line radioembolization. First, the treatment of patients straddling between the intermediate and advanced stages (intermediate patients with bulky or bilobar disease that are considered poor candidates for TACE, and advanced patients with solitary tumors invading a segmental or lobar branch of the portal vein). Second, the treatment of patients that are slightly above the criteria for resection, ablation or transplantation, for which downstaging could open the door for a radical approach. Radioembolization can also be used to treat patients progressing to TACE or sorafenib. With a number of clinical trials underway, the available evidence shows that it adds a significant value to the therapeutic weaponry against HCC of tertiary care centers dealing with this major cancer problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Algaba, F., Patard, J. J., Khoo, V., Eisen, T., & Horwich, A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu259 · Cited by 2,251
Salem, R., Lewandowski, R. J., Mulcahy, M. F., Riaz, A., Ryu, R. K., Ibrahim, S., Atassi, B., Baker, T., Gates, V., Miller, F. H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.006 · Cited by 1,074
Cammà, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., Andreone, P., Craxì, A., & Cottone, M. (2002) · Radiology · doi:10.1148/radiol.2241011262 · Cited by 851
Hepatic toxicity resulting from cancer treatment
Lawrence, T. S., Robertson, J. M., Anscher, M. S., Jirtle, R. L., Ensminger, W. D., & Fajardo, L. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00418-k · Cited by 721
Sangro, B., Carpanese, L., Cianni, R., Golfieri, R., Gasparini, D., Ezziddin, S., Paprottka, P. M., Fiore, F., Van Buskirk, M., Bilbao, J. I., et al. (2011) · Hepatology · doi:10.1002/hep.24451 · Cited by 652
Self-citationSalem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Kulik, L. M., Carr, B. I., Mulcahy, M. F., Lewandowski, R. J., Atassi, B., Ryu, R. K., Sato, K. T., Benson, A., Nemcek, A. A., Gates, V. L., et al. (2008) · Hepatology · doi:10.1002/hep.21980 · Cited by 620
Lewandowski, R. J., Kulik, L. M., Riaz, A., Senthilnathan, S., Mulcahy, M. F., Ryu, R. K., Ibrahim, S. M., Sato, K. T., Baker, T., Miller, F. H., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02695.x · Cited by 582
Raoul, J.-L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.006 · Cited by 537
Self-citationMazzaferro, V., Battiston, C., Perrone, S., Pulvirenti, A., Regalia, E., Romito, R., Sarli, D., Schiavo, M., Garbagnati, F., Marchianò, A., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143301.56154.95 · Cited by 491
Uka, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.414 · Cited by 477
Hilgard, P., Hamami, M., Fouly, A. E., Scherag, A., Müller, S., Ertle, J., Heusner, T., Cicinnati, V. R., Paul, A., Bockisch, A., et al. (2010) · Hepatology · doi:10.1002/hep.23944 · Cited by 458
Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force
U.S. Preventive Services Task Force (1996) · Medical Entomology and Zoology · Cited by 446
Kennedy, A. S., Nutting, C., Coldwell, D., Gaiser, J., & Drachenberg, C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.004 · Cited by 407
Salem, R., Lewandowski, R. J., Atassi, B., Gordon, S. C., Gates, V. L., Barakat, O., Sergie, Z., Wong, C.-Y. O., & Thurston, K. G. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000184594.01661.81 · Cited by 404
Thomas, M. B., Jaffe, D., Choti, M. M., Belghiti, J., Curley, S., Fong, Y., Gores, G., Kerlan, R., Merle, P., O'Neil, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7805 · Cited by 394
Liver disease induced by radioembolization of liver tumors: Description and possible risk factors
Sangro, B., Gil‐Alzugaray, B., Rodriguez, J., Sola, I., Martinez‐Cuesta, A., Viudez, A., Chopitea, A., Iñarrairaegui, M., Arbizu, J., & Bilbao, J. I. (2008) · Cancer · doi:10.1002/cncr.23339 · Cited by 369
Self-citationYttrium-90 microspheres for the treatment of hepatocellular carcinoma
Geschwind, J. F. H., Salem, R., Carr, B. I., Soulen, M. C., Thurston, K. G., Goin, K. A., van Buskirk, M., Roberts, C. A., & Goin, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.034 · Cited by 355
Kulik, L. M., Atassi, B., van Holsbeeck, L., Souman, T., Lewandowski, R. J., Mulcahy, M. F., Hunter, R. D., Nemcek, A. A., Abecassis, M. M., Haines, K. G., et al. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20609 · Cited by 333
Leung, T. W. T., Lau, W.-Y., Ho, S. K. W., Ward, S. C., Chow, J. H. S., Chan, M. S. Y., Metreweli, C., Johnson, P. J., & Li, A. K. C. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00039-3 · Cited by 315
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey, J. E., Shepherd, F. A., Paul, K., et al. (2000) · PubMed · Cited by 295
Raoul, J., Guyader, D., Bretagne, J., Heautot, J., Duvauferrier, R., Bourguet, P., Bekhechi, D., Deugnier, Y. M., & Gosselin, M. (1997) · Hepatology · doi:10.1002/hep.510260511 · Cited by 286
Partial Volume Tolerance of the Liver to Radiation
DAWSON, L., & TENHAKEN, R. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.04.005 · Cited by 273
Golfieri, R., Cappelli, A., Cucchetti, A., Piscaglia, F., Carpenzano, M., Peri, E., Ravaioli, M., D'Errico-Grigioni, A., Pinna, A. D., & Bolondi, L. (2011) · Hepatology · doi:10.1002/hep.24246 · Cited by 264
Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization
Riaz, A., Gates, V. L., Atassi, B., Lewandowski, R. J., Mulcahy, M. F., Ryu, R. K., Sato, K. T., Baker, T., Kulik, L., Gupta, R., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.062 · Cited by 262
Carr, B. I. (2004) · Liver Transplantation · doi:10.1002/lt.20036 · Cited by 261
Riaz, A., Kulik, L., Lewandowski, R. J., Ryu, R. K., Giakoumis Spear, G., Mulcahy, M. F., Abecassis, M., Baker, T., Gates, V., Nayar, R., et al. (2009) · Hepatology · doi:10.1002/hep.22747 · Cited by 260
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
Brown, D. B., Gould, J. E., Gervais, D. A., Goldberg, S. N., Murthy, R., Millward, S. F., Rilling, W. S., Geschwind, J.-F. S., Salem, R., Vedantham, S., et al. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.04.021 · Cited by 257
Lau, W.-Y., Leung, W.-T., Ho, S., Leung, N., Chan, M., Lin, J., Metreweli, C., Johnson, P., & Li, A. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.436 · Cited by 242
Strigari, L., Sciuto, R., Rea, S., Carpanese, L., Pizzi, G., Soriani, A., Iaccarino, G., Benassi, M., Ettorre, G. M., & Maini, C. L. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.075861 · Cited by 239
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Jelic, S., & Sotiropoulos, G. C. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq166 · Cited by 228
Lau, W.-Y., Kennedy, A. S., Kim, Y. H., Lai, H. K., Lee, R.-C., Leung, T. W. T., Liu, C.-S., Salem, R., Sangro, B., Shuter, B., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.08.015 · Cited by 217
Self-citationWang, J.-H., Changchien, C.-S., Hu, T.-H., Lee, C.-M., Kee, K.-M., Lin, C.-Y., Chen, C.-L., Chen, T.-Y., Huang, Y.-J., & Lu, S.-N. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.018 · Cited by 195
Lewandowski, R. J., Mulcahy, M. F., Kulik, L., Riaz, A., Ryu, R. K., Baker, T., Ibrahim, S., Abecassis, M. I., Miller, F. H., Sato, K. T., et al. (2010) · Radiology · doi:10.1148/radiol.10091473 · Cited by 153
Memon, K., Kulik, L., Lewandowski, R. J., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Marshall, K., Gupta, R., Nikolaidis, P., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.054 · Cited by 153
Riaz, A., Memon, K., Miller, F. H., Nikolaidis, P., Kulik, L., Lewandowski, R. J., Ryu, R. K., Sato, K. T., Gates, V. L., Mulcahy, M. F., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.004 · Cited by 145
Goin, J. E., Salem, R., Carr, B. I., Dancey, J. E., Soulen, M. C., Geschwind, J.-F. H., Goin, K., Buskirk, M. V., & Thurston, K. G. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000142602.79459.90 · Cited by 113
Dose distribution following selective internal radiation therapy
Fox, R., Klemp, P., Egan, G., MINA, L. L., Burton, M. A., & Gray, B. N. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90797-8 · Cited by 97
Kennedy, A. S., Kleinstreuer, C., Basciano, C. A., & Dezarn, W. A. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.069 · Cited by 95
Naymagon, S., Warner, R. R. P., Patel, K., Harpaz, N., Macháč, J., Weintraub, J. L., & Kim, M. K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1156-y · Cited by 94
Chen, C., Hu, F.-C., Huang, G., Lee, P., Tsang, Y.-M., Cheng, A., Chen, D., Wang, J., & Sheu, J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.025 · Cited by 79
Güleç, S. A., Sztejnberg, M. L., Siegel, J. A., Jevremović, T., & Stabin, M. G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069278 · Cited by 74
Lau, W. Y., Leung, T. W. T., Ho, S., Chan, M., Leung, N. W. Y., Lin, J., Metreweli, C., & Li, A. K. C. (1994) · British Journal of Radiology · doi:10.1259/0007-1285-67-794-136 · Cited by 42
Transarterial therapies for hepatocellular carcinoma
Sangro, B., D’Avola, D., Iñarrairaegui, M., & Prìeto, J. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.545346 · Cited by 38
Self-citation
Cited by
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Self-citationGoals and targets for personalized therapy for HCC
Couri, T., & Pillai, A. (2019) · Hepatology International · doi:10.1007/s12072-018-9919-1 · Cited by 530
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
Mazzaferro, V., Sposito, C., Bhoori, S., Romito, R., Chiesa, C., Morosi, C., Maccauro, M., Marchianò, A., Bongini, M., Lanocita, R., et al. (2013) · Hepatology · doi:10.1002/hep.26014 · Cited by 517
Treatment of intermediate-stage hepatocellular carcinoma
Forner, A., Gilabert, M., Bruix, J., & Raoul, J.-L. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.122 · Cited by 466
Metadata
- Authors
- Sangro, B., Iñarrairaegui, M., & Bilbao, J. I.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 56
- Issue
- 2
- Pages
- 464-473
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1984101482
- Cited by
- 315
- References
- 52
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.